RAD140 is a non-steroidal selective androgen receptor modulator, or SARM, which is derived from an internal drug discovery program that began in 2005. RAD140 demonstrated potent anabolic activity on muscle and bone in preclinical studies and has completed 28 preclinical toxicology studies of the day in both rats and monkeys. Because of its high anabolic efficacy, receptor selectivity, potent oral activity and long half-life, we believe that RAD140 has clinical potential in a number of indications where the increase in lean muscle mass and / or bone density is useful, as a treatment for weight loss due to cancer cachexia, muscle weakness and osteoporosis.
RAD140, from its internal non-steroidal selective androgen receptor modulator discovery program (“SARM”), for complete preclinical development as a potential therapy for the treatment of age-related muscle loss (sarcopenia) and other osteomuscular conditions which osteoporosis. RAD140 selected the radius from a series of SARMs promise after it demonstrated exceptional selectivity for anabolic activity in well-validated in vivo models the ray expects to terminate conventional toxicology studies that will allow this to make its use significantly safer and more effective compared to prohormones and traditional anabolic steroids.
Boss peptidesRAD140 is a highly effective, oral SARM (selective androgen receptor modulator) currently being studied for both anabolic and neuroprotective effects. It is in Class A of androgen receptor (AR) ligands that are selective tissue, developed to treat muscle wasting associated with cancer, acute and chronic disease and age-related muscle loss.
Recent RAD140 research shows superior lean tissue selectivity and reduced androgenic side effects when compared to the competing compounds of SARM. This compound provides is studying for neuroprotection as well; important neural action of endogenous androgens that is relevant to neural health and resilience to neurodegenerative diseases and to be as effective as testosterone in reducing cell death induced by apoptotic insults.
Testolone (RAD140) from bosspeptides.com is the newest compound in the family of selective androgen receptor modulators, or as they are better known – SARMS. As a result, its main advantage over anabolic steroids is barely offering similar positive results, with all the side effects at all. Indeed, this is quite a unique compound, even when compared to other SARMS.
Few people know this: testosterone and DHT have a natural ability to conserve neurons and have beneficial effects on global neural health. Consequently, it is not surprising that most neurodegenerative terms, such as Alzheimer’s disease, occur in those with androgenic deficiencies. However, using considerable amounts of testosterone can pose other health threats on the long term, as it will cause certain side effects.
RAD140 exerts the same effects in the brain, making it an extremely useful compound for the prevention of neurodegenerative diseases. Furthermore, RAD140 will drastically reduce cell death after suffering from the stroke. Although these neuroprotective properties do not bring an immediate benefit for bodybuilding purposes, they are a very welcome trait.